These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 22216176)
1. Erythroid-specific expression of β-globin from Sleeping Beauty-transduced human hematopoietic progenitor cells. Sjeklocha LM; Park CW; Wong PY; Roney MJ; Belcher JD; Kaufman DS; Vercellotti GM; Hebbel RP; Steer CJ PLoS One; 2011; 6(12):e29110. PubMed ID: 22216176 [TBL] [Abstract][Full Text] [Related]
2. Erythroid-specific expression of beta-globin by the sleeping beauty transposon for Sickle cell disease. Zhu J; Kren BT; Park CW; Bilgim R; Wong PY; Steer CJ Biochemistry; 2007 Jun; 46(23):6844-58. PubMed ID: 17508724 [TBL] [Abstract][Full Text] [Related]
3. Stable transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells, using the Sleeping Beauty transposon system. Sumiyoshi T; Holt NG; Hollis RP; Ge S; Cannon PM; Crooks GM; Kohn DB Hum Gene Ther; 2009 Dec; 20(12):1607-26. PubMed ID: 19689196 [TBL] [Abstract][Full Text] [Related]
4. Detection of Sleeping Beauty transposition in the genome of host cells by non-radioactive Southern blot analysis. Aravalli RN; Park CW; Steer CJ Biochem Biophys Res Commun; 2016 Aug; 477(3):317-21. PubMed ID: 27329815 [TBL] [Abstract][Full Text] [Related]
5. High-level genomic integration, epigenetic changes, and expression of sleeping beauty transgene. Zhu J; Park CW; Sjeklocha L; Kren BT; Steer CJ Biochemistry; 2010 Feb; 49(7):1507-21. PubMed ID: 20041635 [TBL] [Abstract][Full Text] [Related]
6. β-Globin sleeping beauty transposon reduces red blood cell sickling in a patient-derived CD34(+)-based in vitro model. Sjeklocha LM; Wong PY; Belcher JD; Vercellotti GM; Steer CJ PLoS One; 2013; 8(11):e80403. PubMed ID: 24260386 [TBL] [Abstract][Full Text] [Related]
7. The impact of cHS4 insulators on DNA transposon vector mobilization and silencing in retinal pigment epithelium cells. Sharma N; Hollensen AK; Bak RO; Staunstrup NH; Schrøder LD; Mikkelsen JG PLoS One; 2012; 7(10):e48421. PubMed ID: 23110238 [TBL] [Abstract][Full Text] [Related]
8. Recombinant AAV2-mediated β-globin expression in human fetal hematopoietic cells from the aborted fetuses with β-thalassemia major. Tian J; Wang F; Xue JF; Zhao F; Song LJ; Tan MQ Int J Hematol; 2011 Jun; 93(6):691-699. PubMed ID: 21617888 [TBL] [Abstract][Full Text] [Related]
9. Integrating HDAd5/35++ Vectors as a New Platform for HSC Gene Therapy of Hemoglobinopathies. Li C; Psatha N; Wang H; Singh M; Samal HB; Zhang W; Ehrhardt A; Izsvák Z; Papayannopoulou T; Lieber A Mol Ther Methods Clin Dev; 2018 Jun; 9():142-152. PubMed ID: 29766024 [TBL] [Abstract][Full Text] [Related]
11. Gene specificity of suppression of transgene-mediated insertional transcriptional activation by the chicken HS4 insulator. Desprat R; Bouhassira EE PLoS One; 2009 Jun; 4(6):e5956. PubMed ID: 19536296 [TBL] [Abstract][Full Text] [Related]
12. Reactivation of γ-globin in adult β-YAC mice after ex vivo and in vivo hematopoietic stem cell genome editing. Li C; Psatha N; Sova P; Gil S; Wang H; Kim J; Kulkarni C; Valensisi C; Hawkins RD; Stamatoyannopoulos G; Lieber A Blood; 2018 Jun; 131(26):2915-2928. PubMed ID: 29789357 [TBL] [Abstract][Full Text] [Related]
13. Globin vector regulatory elements are active in early hematopoietic progenitor cells. Cabriolu A; Odak A; Zamparo L; Yuan H; Leslie CS; Sadelain M Mol Ther; 2022 Jun; 30(6):2199-2209. PubMed ID: 35247584 [TBL] [Abstract][Full Text] [Related]
14. Gene Therapy for Sickle Cell Disease: A Lentiviral Vector Comparison Study. Urbinati F; Campo Fernandez B; Masiuk KE; Poletti V; Hollis RP; Koziol C; Kaufman ML; Brown D; Mavilio F; Kohn DB Hum Gene Ther; 2018 Oct; 29(10):1153-1166. PubMed ID: 30198339 [TBL] [Abstract][Full Text] [Related]
15. Expression of a human beta-globin transgene in erythroid cells derived from retrovirally transduced transplantable human fetal liver and cord blood cells. Nicolini FE; Imren S; Oh IH; Humphries RK; Leboulch P; Fabry ME; Nagel RL; Eaves CJ Blood; 2002 Aug; 100(4):1257-64. PubMed ID: 12149206 [TBL] [Abstract][Full Text] [Related]
16. RNA interference is responsible for reduction of transgene expression after Sleeping Beauty transposase mediated somatic integration. Rauschhuber C; Ehrhardt A PLoS One; 2012; 7(5):e35389. PubMed ID: 22570690 [TBL] [Abstract][Full Text] [Related]
17. Stable gene transfer to human CD34(+) hematopoietic cells using the Sleeping Beauty transposon. Hollis RP; Nightingale SJ; Wang X; Pepper KA; Yu XJ; Barsky L; Crooks GM; Kohn DB Exp Hematol; 2006 Oct; 34(10):1333-43. PubMed ID: 16982326 [TBL] [Abstract][Full Text] [Related]
18. Optimization of recombinant adeno-associated viral vectors for human beta-globin gene transfer and transgene expression. Maina N; Zhong L; Li X; Zhao W; Han Z; Bischof D; Aslanidi G; Zolotukhin S; Weigel-Van Aken KA; Rivers AE; Slayton WB; Yoder MC; Srivastava A Hum Gene Ther; 2008 Apr; 19(4):365-75. PubMed ID: 18399730 [TBL] [Abstract][Full Text] [Related]
19. Development of virus vectors for gene therapy of beta chain hemoglobinopathies: flanking with a chromatin insulator reduces gamma-globin gene silencing in vivo. Emery DW; Yannaki E; Tubb J; Nishino T; Li Q; Stamatoyannopoulos G Blood; 2002 Sep; 100(6):2012-9. PubMed ID: 12200360 [TBL] [Abstract][Full Text] [Related]
20. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted expression from parvovirus B19p6 promoter in primary human hematopoietic progenitor cells. Kurpad C; Mukherjee P; Wang XS; Ponnazhagan S; Li L; Yoder MC; Srivastava A J Hematother Stem Cell Res; 1999 Dec; 8(6):585-92. PubMed ID: 10645765 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]